Please note, attendees must be registered for Maui Derm to attend this program.
Register @ https://mauiderm.com/maui-derm-hawaii-2025-registration/
Thursday, January 23, 2025
6:00AM – 7:00AM HST: Registration and Breakfast
6:15AM – 7:15AM HST: CME Symposium
Grand Wailea
3850 Wailea Alanui Dr
Wailea, HI 96753
Meeting Room: Haleakala Ballroom
PRESENTING FACULTY
 |
Joel Gelfand, MD, MSCE, FAAD James J. Leyden Professor of Dermatology and of Epidemiology Vice Chair of Clinical Research (Dermatology) Director, Psoriasis and Phototherapy Treatment Center University of Pennsylvania Philadelphia, PA |
 |
April W. Armstrong, MD Professor and Chief of Dermatology University of California Los Angeles Los Angeles, CA |
PROGRAM OVERVIEW
The goal of this program is to provide practicing clinicians with evidence-based strategies to ensure patients who are eligible for systemic therapy are appropriately evaluated and treated to achieve higher levels of skin clearance, optimize patient outcomes, and improve quality of life. This will enable clinicians to develop patient-specific treatment plans that promote long-term outcomes of improved skin clearance and quality of life based on each individual’s unique clinical presentation.
TARGET AUDIENCE
This educational activity is intended for dermatologists and dermatology nurse practitioners and physician assistants involved in the care of patients with psoriasis.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe the evidence-based recommendations for disease severity to appropriately select effective, systemic therapies
- Identify the impact on quality of life associated with special area involvement plaque psoriasis
- Construct patient-centered treatment plans using systemic therapies based on patient candidacy to maximize outcomes and improve quality of life
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
